Product Information

SERTRALINE 200 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $1.4699 per EA under NDC 70710194903. Its NADAC has been published 38 times since Feb 25, 2026.

FDA first approved this application on Jan 29, 2026. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SERTRALINE 200 MG CAPSULE

Sertraline Hydrochloride
$1.4699per EA

Strength

200 mg/1

NDC

70710194903

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

SERTRALINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA220275

FDA Approved

1/29/2026

TE Code

AB

On Market Since

1/29/2026

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for SERTRALINE 200 MG CAPSULE has been published 38 times since Feb 25, 2026, and over the history we have for it it has declined 69.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.4699 per EA
All-time high$4.8130 (Mar 11, 2026)
All-time low$1.4699 (Oct 21, 2026)
52-week high$4.8130
52-week low$1.4699
Median price$2.6866
Average price$3.0435
Largest weekly change-26.5% (Jun 17, 2026)
Weeks tracked38
Tracking sinceFeb 25, 2026

Price History

1W

0.0%

1M

-15.3%

3M

-28.1%

6M

-68.1%

1Y

N/A

3Y

N/A

5Y

N/A

All

-69.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SERTRALINE 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE 200 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $1.4699 per EA (NDC 70710194903), effective Nov 11, 2026.

How has the price of SERTRALINE 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for SERTRALINE 200 MG CAPSULE has declined 69.5%. It has been tracked across 38 weekly CMS publications since Feb 25, 2026.

What are the highest and lowest recorded NADAC prices for SERTRALINE 200 MG CAPSULE?

Since Feb 25, 2026, the NADAC for SERTRALINE 200 MG CAPSULE has ranged from a low of $1.4699 (Oct 21, 2026) to a high of $4.8130 (Mar 11, 2026), with a median of $2.6866 per EA.

Are there cheaper alternatives to SERTRALINE 200 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SERTRALINE 200 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures SERTRALINE 200 MG CAPSULE?

SERTRALINE 200 MG CAPSULE (NDC 70710194903) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.